President
Dr Seth Love
Institute of Clinical Neurosciences
School of Clinical Sciences
University of Bristol
Level 2, Learning & Research
Southmead Hospital
Bristol BS10 5NB
UK
Email: pasl@bristol.ac.uk
Past President
Dr Hitoshi Takahashi
Department of Pathology
Brain Research Institute
1‐757 Asahimachi
Chuo‐ku
Niigata University
Niigata 951‐8585
Japan
Email: hitoshi@bri.niigata-u.ac.jp
Vice‐Presidents
Dr SY Park (Korea), Email: shparknp@snu.ac.kr
Dr S Murayama (Japan), Email: smurayam@tmig.or.jp
Dr Douglas Anthony (USA), Email: douglas_anthony@brown.edu
Secretary‐General
Dr Monika Hofer
Neuropathology and Ocular Pathology
Department
Level 1, West Wing
John Radcliffe Hospital
Oxford OX3 9DU
United Kingdom
Email: monika.hofer@nhs.net
Project Secretary
Dr Audrey Rousseau
Departement de Pathologie Cellulaire et
Tissulaire
PBH
CHU ANGERS
4, rue Larrey
49100 ANGERS
France
Email: audrey.rousseau@univ-angers.fr
Editor of Brain Pathology
Dr Markus Glatzel
Institute of Neuropathology
Universitätsklinikum Hamburg‐Eppendorf
Martinistr. 52
20246 Hamburg
Germany
Email: m.glatzel@uke.de
Treasurer
Dr Stephan Frank
Pathologie Universitätsspital Basel
Schönbeinstrasse 40
CH‐4031 Basel
Email: stephan.frank@anti-clutterusb.ch
Archivist
Dr Maria Thom
Department of Neuropathology
Institute of Neurology
Queen Square
London WC1N 3BG
UK
Email: m.thom@ion.ucl.ac.uk
Chair Training and Development Subcommittee
Dr Raj Kalaria (UK), Email: r.n.kalaria@newcastle.ac.uk
Book Editors
Dr Herbert Budka (Austria), Email: herbert.budka@meduniwien.ac.at
Dr Homa Adle‐Biassette (France), Email: homa.adle@inserm.fr
Ordinary members of the Executive Committee
Dr Marc Del Bigio (Canada), Email: marc.delbigio@umanitoba.ca
Dr Laura Chavez‐Macias (Mexico), Email: laurachm@prodigy.net.mx
Dr Takashi Komori (Japan), Email: komori-tk@igakuken.or.jp
Although most of us agree that no two brain tumours look alike, it is our job to categorize these into a reasonable amount of entities. Fortunately, the neuropathological community has done a great job in developing a sophisticated, multifaceted classification system for central nervous system tumours, which allows us to place the vast majority of neoplasm in adequate drawers. For neuropathologists, categorisation of central nervous system tumours according to the WHO classification and grading system is the gold standard 1. This enables us to speak the same diagnostic language, which is a great achievement and rewarding for neuropathologist, patients and researchers alike. However, there are layers of diagnostically relevant information, which are not included in the WHO classification grading system and which merit to be reported in a standardized way. In the last years, The International Collaboration on Cancer Reporting (ICCR) has brought together panels of experts with the aim to standardize cancer reporting around the world to establish datasets to guide pathology reports. The ICCR has recently published CNS tumor datasets (including histological and molecular parameters) along with copious explanatory notes, which can be found on line at http://www.iccr-cancer.org/datasets/published-datasets/central-nervous-system 2. These ICCR resources may be of use to pathologists and neuropathologists in formulating reports on CNS tumors. A structured approach to reporting relevant neuropathological information will improve the quality of reports and lead to further international harmonization. At Brain Pathology, we welcome this effort and encourage authors, wishing to report a Case of the Month, to follow ICCR reporting guidelines when applicable. For example, one of the Cases of the Month in this issue (April 3 case 2) is a distinctly rare report of an IDH2‐mutant diffuse astrocytoma that required molecular studies to demonstrate that part of the recurrence had a 1p/19q co‐deletion that was not present in the primary tumor.
References
- 1. Louis DNOH. Wiestler OD, Cavenee WK (eds.). World Health Organization Histological Classification of Tumours of the Central Nervous System. Lyon, France; 2016. [Google Scholar]
- 2. Olah M, Louis DN, Brandner S, Brat D, Ellison D, Giangaspero F, Hattab E, Hawkins C, Kleinschmidt‐DeMasters BK, Komori T, McLean C, Paulus W, Perry A, Reifenberger G, Weller M, Wesseling P.Rous B. Tumours of the Central Nervous System (CNS) Reporting Guide. In: International Collaboration on Cancer Reporting: Sydney, Australia; 2018. [DOI] [PubMed]
- 3. Lebrun L, Le Mercier M, Melendez B, Salmon I, D'Haene N (2019) A 47‐year‐old man with a recurrent glioma. Brain Pathol 29:581–582. [DOI] [PMC free article] [PubMed] [Google Scholar]